Vertex Pharmaceuticals Incorporated

Key Statistics

Recent News

• The Death Cross Is Lying: Why Wall Street Is Still Loading Up on Hershey and Vertex 24/7 Wall St.

  The death crosses flashing on both Hershey (NYSE: HSY) and Vertex Pharmaceuticals (NASDAQ: VRTX) are a bearish technical signal that Wall Street is openly ignoring. Analyst consensus on both stocks is

• Vertex Extends Pediatric Pipeline As Shares Trade Below Consensus Targets Simply Wall St.

  Vertex Pharmaceuticals reported pivotal pediatric data for CASGEVY for young children with severe sickle cell disease and beta thalassemia. The company released positive long term and very early age g

• Vertex Pharmaceuticals (VRTX) Rises Higher Than Market: Key Facts Zacks

  In the closing of the recent trading day, Vertex Pharmaceuticals (VRTX) stood at $444.41, denoting a +2% move from the preceding trading day.

• Is Vertex Pharmaceuticals Incorporated (VRTX) A Good Stock To Buy Now? Insider Monkey

  Is VRTX a good stock to buy? We came across a bullish thesis on Vertex Pharmaceuticals Incorporated on r/investing_discussion by Variant_Invest. In this article, we will summarize the bulls’ thesis on

• Vertex Pharmaceuticals (VRTX) Declines More Than Market: Some Information for Investors Zacks

  Vertex Pharmaceuticals (VRTX) concluded the recent trading session at $435.76, signifying a -2.25% move from its prior day's close.

• Kyverna Therapeutics vs. Vertex Pharmaceuticals: Which Drug Developer Stock Is a Better Buy in 2026? Motley Fool

  A clinical-stage innovator faces off against an established biotech powerhouse, each with distinct financials and risk profiles shaping their 2026 outlook.

• Assessing Vertex Pharmaceuticals (VRTX) Valuation After Mixed Recent Returns And Long Term Shareholder Gains Simply Wall St.

  Stock performance snapshot Vertex Pharmaceuticals (VRTX) is drawing investor attention after recent trading left the stock around US$446.83, with returns mixed across different periods and a longer te

• Acadia (ACAD) Down 3.7% Since Last Earnings Report: Can It Rebound? Zacks

  Acadia (ACAD) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.